Consistent and Selective Expression of the Discoidin Domain Receptor-1 Tyrosine Kinase in Human Brain Tumors

Author:

Weiner Howard L.123,Huang Hongyun4,Zagzag David5234,Boyce Hayden4,Lichtenbaum Roger4,Ziff Edward B.672

Affiliation:

1. Division of Pediatric Neurosurgery New York University School of Medicine

2. Kaplan Comprehensive Cancer Center New York University Medical Center, New York, New York

3. Microvascular and Molecular Neuro-Oncology Laboratory New York University Medical Center, New York, New York

4. Departments of Neurosurgery New York University School of Medicine

5. Pathology (Neuro-Pathology) New York University School of Medicine

6. Biochemistry New York University School of Medicine

7. Howard Hughes Medical Institute New York University Medical Center, New York, New York

Abstract

ABSTRACTOBJECTIVEFew molecular targets are both consistently and selectively expressed in a majority of central nervous system (CNS) neoplasms. Receptor tyrosine kinases have been implicated in brain tumor oncogenesis. We previously isolated one such receptor, discoidin domain receptor-1 (DDR1), from high-grade pediatric brain tumors. Here, we analyze the cellular origin and distribution of DDR1 expression in human brain tumors and its expression in tumor cells relative to surrounding brain.METHODSBy use of a digoxigenin-labeled DDR1 riboprobe, we investigated the expression of DDR1 messenger ribonucleic acid in a prospective series of 30 resected human primary and metastatic brain neoplasms, nonneoplastic human brain, and mouse embryonic brain, as well as a mouse glioblastoma model, by in situ hybridization.RESULTSAll the high-grade primary brain and metastatic brain tumors showed unequivocal, intense DDR1 expression within the majority of tumor cells, whereas expression was not observed in hyperplastic tumor blood vessels, normal brain blood vessels, inflammatory cells, or in the normal brain tissue that surrounded the tumor. Receptor expression was limited to tumor cells located within solid tumor tissue. Overall, 27 of 29 resected CNS tumors exhibited tumor cell-specific DDR1 expression, whereas one specimen composed of isolated glioblastoma cells within invaded brain parenchyma showed no detectable staining for this receptor. DDR1 was also expressed preferentially in the ventricular zone (a region of highly proliferating precursor cells) of mice at embryonic Day 15.5.CONCLUSIONWe found that DDR1 is consistently expressed in all high-grade brain neoplasms studied and is selective for tumor cells in the specimens analyzed. The expression of DDR1 by tumor cells of CNS neoplasms and by primitive cells of the embryonic ventricular zone suggests that DDR1 is a potentially useful marker of tumor cells within the CNS.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Surgery

Reference24 articles.

1. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer;Alves;Oncogene,1995

2. Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours;Barker;Oncogene,1995

3. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin;Dahmane;Nature,1997

4. Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues;Di Marco;J Biol Chem,1993

5. Franklin KBJ , PaxinosG The Mouse Brain in Stereotaxic Coordinates. New York, Academic Press, 1997.

Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3